Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Rezvani

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Blood Advances|August 21, 2019
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohortMichael A Spinner, Vanessa E Kennedy, John S Tamaresis, et al.
Cancer|July 25, 2015
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningJennifer E Vaughn, Mohamed L Sorror, Barry E Storer, et al.
Blood Advances|January 4, 2018
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activityMichael A Spinner, Marcelo Fernández-Viña, Lisa E Creary, et al.
Applied and Environmental Microbiology|July 5, 2023
The Tomato Brown Rugose Fruit Virus Movement Protein Gene Is a Novel Microbial Source Tracking MarkerAravind Natarajan, Brayon J Fremin, Danica T Schmidtke, et al.
Transplantation and Cellular Therapy|September 30, 2022
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord BloodChenyu Lin, Gautam Sajeev, Patrick J Stiff, et al.
JCI Insight|May 17, 2019
Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipientsEverett H Meyer, Ginna Laport, Bryan J Xie, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Tomato brown rugose fruit virus Mo gene is a novel microbial source tracking markerAravind Natarajan, Brayon J Fremin, Danica T Schmidtke, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 28, 2024
Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantationAshley L Artese, Michele Sainvil, Laura J Fish, et al.
Transplantation and Cellular Therapy|November 14, 2021
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial OutcomesPaul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Blood Advances|August 21, 2019
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohortMichael A Spinner, Vanessa E Kennedy, John S Tamaresis, et al.
Cancer|July 25, 2015
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningJennifer E Vaughn, Mohamed L Sorror, Barry E Storer, et al.
Blood Advances|January 4, 2018
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activityMichael A Spinner, Marcelo Fernández-Viña, Lisa E Creary, et al.
Applied and Environmental Microbiology|July 5, 2023
The Tomato Brown Rugose Fruit Virus Movement Protein Gene Is a Novel Microbial Source Tracking MarkerAravind Natarajan, Brayon J Fremin, Danica T Schmidtke, et al.
Transplantation and Cellular Therapy|September 30, 2022
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord BloodChenyu Lin, Gautam Sajeev, Patrick J Stiff, et al.
JCI Insight|May 17, 2019
Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipientsEverett H Meyer, Ginna Laport, Bryan J Xie, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Tomato brown rugose fruit virus Mo gene is a novel microbial source tracking markerAravind Natarajan, Brayon J Fremin, Danica T Schmidtke, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 28, 2024
Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantationAshley L Artese, Michele Sainvil, Laura J Fish, et al.
Transplantation and Cellular Therapy|November 14, 2021
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial OutcomesPaul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, et al.
Pageof 7